Millennium reports 5.0% stake in Omnicell (2.29M sh)
Omnicell, Inc. Schedule 13G discloses that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report shared beneficial ownership of 2,288,570 shares of Omnicell common stock, representing 5.0% of the class.
Rhea-AI Filing Summary
Omnicell, Inc. Schedule 13G discloses that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report shared beneficial ownership of 2,288,570 shares of Omnicell common stock, representing 5.0% of the class. The filing is a joint filing and is signed by the reporting parties.
The filing states the shares are held by entities over which reporting persons have voting and investment discretion and provides the reporting persons' addresses and citizenships. Exhibit I is a Joint Filing Agreement dated March 31, 2026.
Positive
- None.
Negative
- None.
Insights
Joint holders report a 5.0% shared stake via Millennium-related entities.
The filing lists 2,288,570 shares as shared voting and dispositive power among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. This identifies a non‑controlling but notable passive stake disclosed under Schedule 13G conventions.
Key dependencies include the holdings being held through affiliated entities and governed by a Joint Filing Agreement dated March 31, 2026. Subsequent filings may update percent ownership if positions change.
Key Figures
Key Terms
Schedule 13G regulatory
Joint Filing Agreement legal
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Millennium Management report in OMCL?
Who signed the Schedule 13G for OMCL?
What document governs the joint filing of the OMCL position?
What is the reporting class and CUSIP for the OMCL filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.